Article Information
PubMed
Published By
Online ISSN
History
- Received July 26, 2022
- Accepted October 16, 2022
- Published online December 1, 2022.
Article Versions
- You are currently viewing a previous version of this article (December 1, 2022 - 07:51).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Ventzislava A. Hristova1,15,
- Alastair Watson2,3,15,
- Raghothama Chaerkady1,
- Matthew S. Glover1,
- Jodie Ackland2,
- Bastian Angerman4,
- Graham Belfield5,
- Maria G. Belvisi6,7,
- Hannah Burke2,8,
- Doriana Cellura2,
- Howard W. Clark9,10,
- Damla Etal5,
- Anna Freeman2,8,
- Ashley I Heinson2,
- Sonja Hess1,
- Michael Hühn4,
- Emily Hall2,
- Alex Mackay4,7,
- Jens Madsen2,
- Christopher McCrae11,
- Daniel Muthas4,
- Steven Novick12,
- Kristoffer Ostridge2,4,
- Lisa Öberg4,
- Adam Platt13,
- Anthony D. Postle2,
- C. Mirella Spalluto2,
- Outi Vaarala14,
- Junmin Wang1,
- Karl J. Staples2,8 and
- Tom M.A Wilkinson2,8⇑
- on behalf of the MICA II Study group16
- 1Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA
- 2Faculty of Medicine, University of Southampton, Southampton, UK
- 3School of Clinical Medicine, University of Cambridge, Cambridge, UK
- 4Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 5Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 6Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 7NHLI, Imperial College, London, UK
- 8NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK
- 9Neonatology, Faculty of Population Health Sciences, EGA Institute for Women's Health, University College London, London, UK
- 10NIHR University College London Hospital Biomedical Research, University College London Hospital, London, UK
- 11Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA
- 12Data Sciences & Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA
- 13Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 14Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 15These authors contributed equally to this work
- 16For MICAII study group see end of manuscript
- Corresponding author: Tom Wilkinson (T.Wilkinson{at}soton.ac.uk)
Funding
AstraZeneca
Article usage
Altmetrics
Vol 9 Issue 5
Table of Contents
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD
